Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 304

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study

Open access
Ross-Innes, Caryn S., Debiram-Beecham, Irene, O'Donovan, Maria, Walker, Elaine, Varghese, Sibu, Lao-Sirieix, Pierre, Lovat, Laurence, Griffin, Michael, Ragunath, Krish, Haidry, Rehan, Sami, Sarmed S., Kaye, Philip, Novelli, Marco, Disep, Babett, Ostler, Richard, Aigret, Benoit, North, Bernard V., Bhandari, Pradeep, Haycock, Adam, Morris, Danielle, Attwood, Stephen, Dhar, Anjan, Rees, Colin, Rutter, Matthew D. D., Sasieni, Peter D., Fitzgerald, Rebecca C., on behalf of the BEST2 Study Group·2015·PLOS Medicine

Abstract

BACKGROUND: Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophageal adenocarcinoma. Routine endoscopic screening for BE is not recommended because of the burden this would impose on the health care system. The objective of this study was to determine whether a novel approach using a minimally invasive cell sampling device, the Cytosponge, coupled with immunohistochemical staining for the biomarker Trefoil Factor 3 (TFF3), could be used to identify patients who warrant endoscopy to diagnose BE. METHODS AND FINDINGS: A case-control study was performed across 11 UK hospitals between July 2011 and December 2013. In total, 1,110 individuals comprising 463 controls with dyspepsia and reflux symptoms and 647 BE cases swallowed a Cytosponge prior to endoscopy. The primary outcome measures were to evaluate the safety, acceptability, and accuracy of the Cytosponge-TFF3 test compared with endoscopy and biopsy. In all, 1,042 (93.9%) patients successfully swallowed the Cytosponge, and no serious adverse events were attributed to the device. The Cytosponge was rated favorably, using a visual analogue scale, compared with endoscopy (p < 0.001), and patients who were not sedated for endoscopy were more likely to rate the Cytosponge higher than endoscopy (Mann-Whitney test, p < 0.001). The overall sensitivity of the test was 79.9% (95% CI 76.4%-83.0%), increasing to 87.2% (95% CI 83.0%-90.6%) for patients with ≥3 cm of circumferential BE, known to confer a higher cancer risk. The sensitivity increased to 89.7% (95% CI 82.3%-94.8%) in 107 patients who swallowed the device twice during the study course. There was no loss of sensitivity in patients with dysplasia. The specificity for diagnosing BE was 92.4% (95% CI 89.5%-94.7%). The case-control design of the study means that the results are not generalizable to a primary care population. Another limitation is that the acceptability data were limited to a single measure. CONCLUSIONS: The Cytosponge-TFF3 test is safe and acceptable, and has accuracy comparable to other screening tests. This test may be a simple and inexpensive approach to identify patients with reflux symptoms who warrant endoscopy to diagnose BE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1001780

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 304

Metadata

Authors
Ross-Innes, C. S., Debiram-Beecham, I., O'Donovan, M., Walker, E., Varghese, S., Lao-Sirieix, P., Lovat, L., Griffin, M., Ragunath, K., Haidry, R., Sami, S. S., Kaye, P., Novelli, M., Disep, B., Ostler, R., Aigret, B., North, B. V., Bhandari, P., Haycock, A., Morris, D., Attwood, S., Dhar, A., Rees, C., Rutter, M. D. D., Sasieni, P. D., Fitzgerald, R. C., & on behalf of the BEST2 Study Group
Venue
PLOS Medicine
Published
2015-01-29
Volume
12
Issue
1
Pages
e1001780
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2051570610
Cited by
304
References
29
FWCI
29.69
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study. https://app.cochat.ai/papers/10.1371/journal.pmed.1001780
The paper
Ross-Innes, C. S., Debiram-Beecham, I., O'Donovan, M., Walker, E., Varghese, S., Lao-Sirieix, P., Lovat, L., Griffin, M., Ragunath, K., Haidry, R., Sami, S. S., Kaye, P., Novelli, M., Disep, B., Ostler, R., Aigret, B., North, B. V., Bhandari, P., Haycock, A., . . . on behalf of the BEST2 Study Group. (2015). Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1001780

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.